Literature DB >> 1504710

Effect of metformin on glucose metabolism in the splanchnic bed.

C J Bailey1, C Wilcock, C Day.   

Abstract

1. Use of the antihyperglycaemic agent, metformin, is often associated with a small rise in circulating lactate. This study investigates the source of the lactate and examines the effect of metformin on glucose metabolism by the intestine and liver of rats. 2. Changes in plasma glucose and lactate were measured in the inferior vena cava (IVC), hepatic portal vein (HPV), hepatic vein (HV) and aorta (A) after intrajejunal administration of metformin (50 and 250 mg kg-1) without and with glucose (2 g kg-1). 3. Metformin 250 mg kg-1 reduced the hyperglycaemic response to a glucose challenge, associated with a greater reduction of glucose concentrations in the HPV (average decrease of 33% at 60 and 120 min) than at other sites. 4. Both doses of metformin increased lactate concentrations in the glucose-loaded state: the highest concentration (2.5 fold increase) was recorded in the HPV 60 min after administration of 250 mg kg-1 metformin, with a high lactate concentration persisting in the HV at 120 min. Metformin 250 mg kg-1 also increased lactate concentrations in the basal state, with highest concentrations (2 fold increase) in the HPV. 5. Two hours after intrajejunal administration of metformin, 50 mg kg-1, rings of tissue from the small intestine showed an average 22% decrease in glucose oxidation ([14C]-glucose conversion to 14CO2) and a 10% increase in lactate production. Since glucose metabolism in the gut is predominantly anaerobic, metformin caused an overall 9.5% increase of intestinal glucose utilization.6. Metformin, 10-6 and I0- mol 1', did not significantly alter glucose oxidation or lactate production by isolated hepatocytes, but a very high concentration of metformin (102 mol 1') increased lactate production by 60%.7. The results support the view that metformin increased intestinal glucose utilization and lactate production by the intestine. Under basal conditions there was net extraction of lactate by the liver but not after an enteral glucose load.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1504710      PMCID: PMC1908709          DOI: 10.1111/j.1476-5381.1992.tb09093.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  18 in total

1.  Sites of metformin-stimulated glucose metabolism.

Authors:  C Wilcock; C J Bailey
Journal:  Biochem Pharmacol       Date:  1990-06-01       Impact factor: 5.858

2.  Reconsideration of inhibitory effect of metformin on intestinal glucose absorption.

Authors:  C Wilcock; C J Bailey
Journal:  J Pharm Pharmacol       Date:  1991-02       Impact factor: 3.765

3.  Effects of metformin on glucose uptake by isolated diaphragm from normal and diabetic rats.

Authors:  K N Frayn; P I Adnitt
Journal:  Biochem Pharmacol       Date:  1972-12-01       Impact factor: 5.858

4.  Inhibition of intestinal absorption and improvement of oral glucose tolerance by biguanides in the normal and in the streptozotocin-diabetic rat.

Authors:  E Lorch
Journal:  Diabetologia       Date:  1971-06       Impact factor: 10.122

Review 5.  Metformin revisited: its actions and indications for use.

Authors:  C J Bailey
Journal:  Diabet Med       Date:  1988 May-Jun       Impact factor: 4.359

6.  Subcellular distribution of metformin in rat liver.

Authors:  C Wilcock; N D Wyre; C J Bailey
Journal:  J Pharm Pharmacol       Date:  1991-06       Impact factor: 3.765

7.  Metformin kinetics in healthy subjects and in patients with diabetes mellitus.

Authors:  G T Tucker; C Casey; P J Phillips; H Connor; J D Ward; H F Woods
Journal:  Br J Clin Pharmacol       Date:  1981-08       Impact factor: 4.335

8.  Pharmacokinetics of metformin after intravenous and oral administration to man.

Authors:  P J Pentikäinen; P J Neuvonen; A Penttilä
Journal:  Eur J Clin Pharmacol       Date:  1979-09       Impact factor: 2.953

9.  Effect of metformin on insulin-stimulated glucose turnover and insulin binding to receptors in type II diabetes.

Authors:  R Nosadini; A Avogaro; R Trevisan; A Valerio; P Tessari; E Duner; A Tiengo; M Velussi; S Del Prato; S De Kreutzenberg
Journal:  Diabetes Care       Date:  1987 Jan-Feb       Impact factor: 19.112

10.  Effect of metformin on glucose metabolism in mouse soleus muscle.

Authors:  C J Bailey; J A Puah
Journal:  Diabete Metab       Date:  1986-08
View more
  38 in total

1.  Metformin: historical overview.

Authors:  Clifford J Bailey
Journal:  Diabetologia       Date:  2017-08-03       Impact factor: 10.122

2.  Clinical pharmacology physiology conference: metformin and lactic acidosis (LA).

Authors:  Chadi Alkhalil; George Zavros; Fadi Bailony; David T Lowenthal
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

3.  Metformin and the intestine.

Authors:  C J Bailey; C Wilcock; J H B Scarpello
Journal:  Diabetologia       Date:  2008-06-05       Impact factor: 10.122

Review 4.  A risk-benefit assessment of metformin in type 2 diabetes mellitus.

Authors:  H C Howlett; C J Bailey
Journal:  Drug Saf       Date:  1999-06       Impact factor: 5.606

Review 5.  The antihyperglycaemic effect of metformin: therapeutic and cellular mechanisms.

Authors:  N F Wiernsperger; C J Bailey
Journal:  Drugs       Date:  1999       Impact factor: 9.546

6.  Lactic acidosis in metformin therapy.

Authors:  J D Lalau; J M Race
Journal:  Drugs       Date:  1999       Impact factor: 9.546

7.  The Association between Metformin Therapy and Lactic Acidosis.

Authors:  Isabelle H S Kuan; Ruth L Savage; Stephen B Duffull; Robert J Walker; Daniel F B Wright
Journal:  Drug Saf       Date:  2019-12       Impact factor: 5.606

Review 8.  Metformin: new understandings, new uses.

Authors:  Ripudaman S Hundal; Silvio E Inzucchi
Journal:  Drugs       Date:  2003       Impact factor: 9.546

9.  Prediction and validation of enzyme and transporter off-targets for metformin.

Authors:  Sook Wah Yee; Lawrence Lin; Matthew Merski; Michael J Keiser; Aakash Gupta; Youcai Zhang; Huan-Chieh Chien; Brian K Shoichet; Kathleen M Giacomini
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-09-03       Impact factor: 2.745

Review 10.  Therapeutic Concentrations of Metformin: A Systematic Review.

Authors:  Farshad Kajbaf; Marc E De Broe; Jean-Daniel Lalau
Journal:  Clin Pharmacokinet       Date:  2016-04       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.